Winter mornings increase the risk of cardiovascular conditions: Dr. Manjinder Sandhu
According to a German study, temperature drops (up to 2.9 degrees over 24 hours) result in an increase in heart...
cardiovascular
Dapagliflozin significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial
Detailed results from the DELIVER Phase III trial showed AstraZeneca’s dapagliflozin significantly reduced the composite of cardiovascular (CV) death or worsening...
